| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.54B | +0.7% |
| R&D Expense | $27.0M | -22.9% |
| SG&A Expense | $973.0M | -4.8% |
| Operating Income | $535.0M | -31.5% |
| Interest Expense | $95.0M | +0.0% |
| Pre-tax Income | $643.0M | -24.6% |
| Income Tax | $93.0M | -45.9% |
| Net Income | $550.0M | -19.2% |
| EPS (Basic) | $13.96 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $212.0M | -54.0% |
| Current Assets | $3.23B | +12.1% |
| Total Assets | $12.14B | +8.3% |
| Current Liabilities | $2.99B | -1.4% |
| Long-term Debt | $2.70B | +22.0% |
| Total Liabilities | $7.47B | +5.0% |
| Stockholders' Equity | $4.67B | +14.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $393.0M | -59.5% |
| Capital Expenditures | $367.0M | +25.7% |
| Investing Cash Flow | -$348.0M | -47.5% |
| Financing Cash Flow | $356.0M | +146.2% |
| Free Cash Flow | $26.0M | -96.2% |
| -18.2% |
| EPS (Diluted) | $13.96 | -18.2% |